Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133654) titled 'Bidirectional Cohort Study on Postoperative Adjuvant Therapy with Transarterial Chemoembolization Combined with Anti-PD-1 Antibody With or Without Donafenib in Hepatocellular Carcinoma Patients at High Risk of Recurrence' on Sept. 30.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Condition:
Liver cancer
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-30
Target Sample Size: Observation group of postoperative adjuvant therapy for patients with hepatocellular car...